News Releases

Boston Scientific To Participate In 36th Annual J.P. Morgan Healthcare Conference

Dec 22, 2017

MARLBOROUGH, Mass., Dec. 22, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 36th annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 in San Francisco, CA.

Mike Mahoney, chairman and chief executive officer, will present at approximately 8:00 a.m. PT. At 8:30 a.m. PT, Mike will be joined by Dan Brennan, executive vice president and chief financial officer, Professor Ian Meredith, executive vice president and global chief medical officer and Susie Lisa, vice president, Investor Relations, in a question-and-answer session with the host analyst and audience members.

A live webcast of the presentation and question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

Media: 

Investors:

Kate Haranis

Susie Lisa, CFA

508-683-6585 (office)

508- 683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

Kate.Haranis@bsci.com                                          

investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation